Literature DB >> 8264968

No age-related changes in human benzodiazepine receptor binding measured by PET with [11C]Ro 15-4513.

T Suhara1, O Inoue, K Kobayashi, K Suzuki, T Itoh, Y Tateno.   

Abstract

The effects of age on the binding of [11C]Ro 15-4513, a partial inverse agonist of the central benzodiazepine receptor, were studied. Sixteen healthy male volunteers (21-78 years old) participated. Regional radioactivity in the brain was followed for 45 min by positron emission tomography after a bolus injection of [11C]Ro 15-4513. Similar tracer kinetics were observed in both young and old subjects. For the quantification of receptor binding in vivo, a compartment model, in which radioactivity in the pons was used as an input function, was applied. There were no significant changes in the binding potentials with age (P > 0.1) in ten brain regions. These observations delineate an interesting difference between central benzodiazepine (BZ) receptors and other neurotransmitter receptors in the human brain measured by PET that have been shown to have a reduction with age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264968     DOI: 10.1016/0304-3940(93)90835-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Distribution of cortical benzodiazepine receptor binding in right-handed healthy humans: a voxel-based statistical analysis of iodine 123 iomazenil SPECT with partial volume correction.

Authors:  H Kato; E Shimosegawa; K Isohashi; N Kimura; H Kazui; J Hatazawa
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

2.  Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513.

Authors:  Luanda J Pym; Susan M Cook; Thomas Rosahl; Ruth M McKernan; John R Atack
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 3.  Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Authors:  V Ozdemir; J Fourie; U Busto; C A Naranjo
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.